Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

275.84 USD -4.45 (-1.59%)
Official Closing Price Updated: 7:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. 
From Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For November 10, 2020
Upgrades According to DA Davidson, the prior rating for Wayfair Inc (NYSE: W) was changed from Neutral to Buy. Wayfair earned ... 
Tags Initiation WST RL
From Benzinga
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TCRR CALT OCUL
From Benzinga
100 Biggest Movers From Yesterday
Gainers Sundial Growers Inc. (NASDAQ: SNDL) shares surged 83.4% to close at $0.4585 on Monday after gaining over 13% on Friday. ... 
Tags OSW Top Gainers CNK
From Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. 
From Business Wire News Releases
The Also-Rans
The big news that Pfizer has cured COVID-19 isn’t such great news for other public companies involved in testing and other companies that were racing for their own version of a vaccine. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
74 Stocks Moving In Monday's Mid-Day Session
Gainers Sundial Growers Inc. (NASDAQ: SNDL) shares climbed 81.4% to $0.4535 after gaining over 13% on Friday. Sundial Growers is ... 
Tags BKD Computer Storage & Peripherals SITC
From Benzinga
Why This Biogen Analyst Says The FDA Could Still Approve Aducanumab
Biogen Inc (NASDAQ: BIIB) shares are retreating sharply after an Adcom committee recommended against approval of ... 
Tags Reiteration Benzinga Market News
From Benzinga
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Biogen Inc. – BIIB
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Biogen Inc. (NASDAQ: BIIB) resulting from allegations that... 
From Business Wire News Releases
Nasdaq 100 Movers: BIIB, ULTA
In early trading on Monday, shares of Ulta Beauty topped the list of the day's best performing components of the Nasdaq 100 index, trading up 23.5%. Year to date, Ulta Beauty registers a 4.9% gain. 
Tags Stocks
From Market News Video
S&P 500 Movers: BIIB, KIM
In early trading on Monday, shares of Kimco Realty topped the list of the day's best performing components of the S&P 500 index, trading up 33.4%. Year to date, Kimco Realty has lost about 33.9% of its... 
Tags Stocks
From Market News Video
Should you invest in Bank of America, Biogen, Macy's, Tilray, or Ulta Beauty?
InvestorsObserver issues critical PriceWatch Alerts for BAC, BIIB, M, TLRY, and ULTA. 
From PR Newswire
ROCE Insights For Biogen
Biogen (NASDAQ: BIIB) posted Q3 earnings of $1.13 billion, an increase from Q2 of 43.66%. Sales dropped to $3.38 billion, a 8.31% ... 
Tags News BIIB Earnings
From Benzinga
Benzinga's Top Upgrades, Downgrades For November 9, 2020
Upgrades According to UBS, the prior rating for Yelp Inc (NYSE: YELP) was changed from Sell to Neutral. Yelp earned $0.01 in the ... 
Tags VIRT HMSY SNDR
From Benzinga
Biogen Stock Crashes After FDA Panel Rejects Alzheimer's Treatment
Biogen stock crashed Monday after a Food and Drug Administration panel voted against recommending its controversial Alzheimer's treatment for approval. Shares were down more than 30% early. 
From Investor's Business Daily
Dow Jones Today, Stock Futures Spike 1,500 Points On Biden Presidency, Pfizer Vaccine News
The Dow Jones today soared more than 1,500 points, Pfizer and BioNTech spiked on coronvirus vaccine news as markets valued in a Joe Biden presidency. 
From Investor's Business Daily
Analysts Predict Volatility In Biogen Shares Until March 2021
Wall Street analysts suggest thatBiogen Inc(NASDAQ:BIIB) stock is about to see a significant selloff and could witness ... 
Tags Trading Ideas General Analyst Ratings
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags SILK MRK LIFE
From Benzinga
Barron's Picks And Pans: Apollo Global, Biogen, Biden Picks And More
This weekend's Barron's examines how Biden won an extraordinary electionand what a Biden administration could ... 
Tags Amazon MSFT FB
From Benzinga
Biogen's Aducanumab Fails To Win FDA Panel Backing
Biogen Inc. failed to win the backing of the FDA panel which reviewed the BLA for its controversial Alzheimer's drug aducanumab, an antibody which targets amyloid-beta. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Stock Market Rally Analysis; Alibaba, Nvidia In Buy Range; Biogen, Nio, Tesla, Xpeng, Li Auto In Focus
Last week's market rally showed real power. Biogen is in focus after a FDA panel panned its Alzheimer's drug. China EV sales are due for Tesla and Nio. 
From Investor's Business Daily
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
From GlobeNewswire News Releases
Biogen's Aducanumab Fails To Win FDA Panel Backing
Biogen Inc (NASDAQ: BIIB) failed to win the backing of the FDA panel which reviewed the BLA for its controversial Alzheimer's drug ... 
Tags Biotech BIIB LLY
From Benzinga
Biogen Stock Halted As FDA Panel Prepares To Discuss Alzheimer's Drug
Biogen stock was halted early Friday ahead of a Food and Drug Administration advisory committee meeting to discuss the fate of its controversial Alzheimer's treatment, aducanumab. 
From Investor's Business Daily
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News Pre/Market Outlook ZBH
From Benzinga
Lam Research Now #115 Largest Company, Surpassing Biogen
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Lam Research Corp (LRCX) has taken over the #115 spot from Biogen Inc (BIIB), according to The... 
Tags Stocks
From Market News Video
Biogen Analysts Brace For Favorable Aducanumab Adcom Verdict
Biogen Inc (NASDAQ: BIIB) shares saw a nice 40% bumpWednesday following the release of FDA briefing document prepared for ... 
Tags Analyst Ratings General Thomas Shrader
From Benzinga
Thursday's ETF Movers: TAN, FBT
In trading on Thursday, the Invesco Solar ETF is outperforming other ETFs, up about 10.9% on the day. Components of that ETF showing particular strength include shares of Jinkosolar Holding, up about... 
Tags ETFs
From ETF Channel
Investors Cheer Gridlock Potential That Could Prevent Tax, Tech, Health Care Overhauls
It’s often been said that the stock market dislikes uncertainty. So it may be a little bit of a surprise that the market rally is ... 
Tags QCOM Economics News
From Benzinga
Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics
Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration officials said there was enough evidence in... 
Tags Health/Care Commodities Medical Products
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.